Evidence map›Paper›PMID 31824156›Full record

ArticleInternational journal of nanomedicine2019

cRGD-Conjugated Fe

Xi Fan, Zeting Yuan, Chenting Shou, Guohua Fan, Hong Wang, Feng Gao, Yuanpeng Rui, Ke Xu, Peihao Yin

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Photothermal FeJournal of nanobiotechnology · 2024
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Xi Fan *Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
Zeting Yuan *Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
Chenting Shou *Department of Pharmaceutics, School of Pharmacy, East China University of Science and Technology, Shanghai, People's Republic of China.
Guohua FanInterventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
Hong WangSchool of Medicine and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
Feng GaoDepartment of Pharmaceutics, School of Pharmacy, East China University of Science and Technology, Shanghai, People's Republic of China.
Yuanpeng RuiDepartment of Image, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.ORCID 0000-0001-6795-8617
Ke XuInterventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.ORCID 0000-0002-3942-2767
Peihao YinInterventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.ORCID 0000-0002-7443-4018
Shanghai University of Traditional Chinese Medicine · CNEast China University of Science and Technology · CNAnhui Medical University · CNChengdu University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPhotothermal therapy (PTT) has great potential in the clinical treatment of tumors. However, most photothermal materials are difficult to apply due to their insufficient photothermal conversion efficiencies (PCEs), poor photostabilities and short circulation times. Furthermore, tumor recurrence is likely to occur using PTT only. In the present study, we prepared cyclo (Arg-Gly-Asp-d-Phe-Cys) [c(RGD)] conjugated doxorubicin (DOX)-loaded Fe MATERIALS AND

methodsCytotoxicity of Fe

resultsFe

conclusionAccording to our results, Fe

Indexed as

Hyperthermia, InducedMagnetic Resonance ImagingPhototherapyAnimalsAntineoplastic AgentsCell DeathCombined Modality TherapyDoxorubicinDrug LiberationEndocytosisFerric CompoundsHCT116 CellsHumansIndolesMaleMice, NudeAntineoplastic Agentscyclic arginine-glycine-aspartic acid peptideDoxorubicinFerric Compoundsferric oxideIndolesPeptides, CyclicpolydopaminePolymerschemo-photothermal therapycRGDFe3O4 nanoparticlesmagnetic resonance imagingMRIpolydopaminetumor target

Identifiers

PMID31824156
PMCPMC6901060
OpenAlexW2993381695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.